Lv1
54 积分 2022-09-06 加入
Trispecific antibodies: From challenges to integration in cancer therapy
4天前
已完结
Structural and mechanistic insights into peptidylarginine deiminase (PAD2/PAD4) mediated citrullination and therapeutic targeting: A review
6天前
已完结
Synergistic Cytotoxic Effect on Gastric Cancer Cells of an Immunotoxin Cocktail in Which Antibodies Recognize Different Epitopes on CDH17
13天前
已完结
Efficacy and preclinical safety of ARB202, a potential first-in-class anti-CDH17/CD3 bispecific T-cell engager, for treatment of pancreatic and colorectal cancers
13天前
已关闭
Rheumatoid arthritis-specific autoantibodies to peptidyl arginine deiminase type 4 inhibit citrullination of fibrinogen
16天前
已完结
Peptidylarginine deiminase (PAD): A promising target for chronic diseases treatment
17天前
已完结
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
18天前
已完结
An Anti-B7-H4 Antibody–Drug Conjugate for the Treatment of Breast Cancer
20天前
已完结
Development of a high-affinity anti-ROR1 variable region for broad anti-cancer immunotherapy
1个月前
已完结
PIT565, a First-in-Class Anti-CD19, Anti-CD3, Anti-CD2 Trispecific Antibody for the Treatment of B Cell Malignancies
1个月前
已完结